NCT06319014 Physical Activity to Mitigate PreEclampsia Risk
| NCT ID | NCT06319014 |
| Status | Recruiting |
| Phase | — |
| Sponsor | East Carolina University |
| Condition | Pre-Eclampsia |
| Study Type | INTERVENTIONAL |
| Enrollment | 224 participants |
| Start Date | 2024-06-24 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 224 participants in total. It began in 2024-06-24 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will decrease severity and occurrence of preeclampsia symptoms, thus improving maternal, pregnancy, and birth outcomes. Aim 1. Determine the influence of different exercise modes during pregnancy at risk of preeclampsia on maternal cardiometabolic health. Aim 2. Determine the most effective exercise mode in pregnancy at risk of preeclampsia on improving birth and infant health outcomes.
Eligibility Criteria
Inclusion Criteria: * healthy women, age 18-40 years, \<16 weeks' gestation, with singleton pregnancy; women (BMI:18.5-45.0), sedentary, cleared by their obstetric provider. Exclusion Criteria: * pre-existing chronic conditions such as HIV, lupus, etc.; taking medicines that affect fetal development; and/or lack of telephone or email contact information).
Contact & Investigator
Linda E May, MS, PhD
PRINCIPAL INVESTIGATOR
East Carolina University
Frequently Asked Questions
Who can join the NCT06319014 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Pre-Eclampsia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06319014 currently recruiting?
Yes, NCT06319014 is actively recruiting participants. Contact the research team at mayl@ecu.edu for enrollment information.
Where is the NCT06319014 trial being conducted?
This trial is being conducted at Greenville, United States.
Who is sponsoring the NCT06319014 clinical trial?
NCT06319014 is sponsored by East Carolina University. The principal investigator is Linda E May, MS, PhD at East Carolina University. The trial plans to enroll 224 participants.